Avian antimicrobial peptides: in vitro and in ovo characterization and protection from early chick mortality caused by yolk sac infection

Abstract Increasing antibiotic resistance is a matter of grave concern for consumers, public health authorities, farmers, and researchers. Antimicrobial peptides (AMPs) are emerging as novel and effective non-antibiotic tools to combat infectious diseases in poultry. In this study, we evaluated six...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Thuy Thi Thu Nguyen, Brenda Allan, Colette Wheler, Wolfgang Köster, Volker Gerdts, Arshud Dar
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2021
Materias:
R
Q
Acceso en línea:https://doaj.org/article/9fb659bc8a2141f095f103ae0b6508dc
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:9fb659bc8a2141f095f103ae0b6508dc
record_format dspace
spelling oai:doaj.org-article:9fb659bc8a2141f095f103ae0b6508dc2021-12-02T15:23:38ZAvian antimicrobial peptides: in vitro and in ovo characterization and protection from early chick mortality caused by yolk sac infection10.1038/s41598-021-81734-22045-2322https://doaj.org/article/9fb659bc8a2141f095f103ae0b6508dc2021-01-01T00:00:00Zhttps://doi.org/10.1038/s41598-021-81734-2https://doaj.org/toc/2045-2322Abstract Increasing antibiotic resistance is a matter of grave concern for consumers, public health authorities, farmers, and researchers. Antimicrobial peptides (AMPs) are emerging as novel and effective non-antibiotic tools to combat infectious diseases in poultry. In this study, we evaluated six avian AMPs including 2 truncated cathelicidins, [CATH-1(6–26) and CATH-2(1–15)], and 4 avian β-defensins (ABD1, 2, 6 and 9) for their bactericidal and immunomodulatory activities. Our findings have shown CATH-1(6–26) and ABD1 being the two most potent avian AMPs effective against Gram-positive and Gram-negative bacteria investigated in these studies. Moreover, CATH-1(6–26) inhibited LPS-induced NO production and exhibited dose-dependent cytotoxicity to HD11 cells. While, ABD1 blocked LPS-induced IL-1β gene induction and was non-toxic to HD11 cells. Importantly, in ovo administration of these AMPs demonstrated that ABD1 can offer significant protection from early chick mortality (44% less mortality in ABD1 treated group versus the control group) due to the experimental yolk sac infection caused by avian pathogenic Escherichia coli. Our data suggest that in ovo administration of ABD1 has immunomodulatory and anti-infection activity comparable with CpG ODN. Thus, ABD1 can be a significant addition to potential alternatives to antibiotics for the control of bacterial infections in young chicks.Thuy Thi Thu NguyenBrenda AllanColette WhelerWolfgang KösterVolker GerdtsArshud DarNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 11, Iss 1, Pp 1-14 (2021)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Thuy Thi Thu Nguyen
Brenda Allan
Colette Wheler
Wolfgang Köster
Volker Gerdts
Arshud Dar
Avian antimicrobial peptides: in vitro and in ovo characterization and protection from early chick mortality caused by yolk sac infection
description Abstract Increasing antibiotic resistance is a matter of grave concern for consumers, public health authorities, farmers, and researchers. Antimicrobial peptides (AMPs) are emerging as novel and effective non-antibiotic tools to combat infectious diseases in poultry. In this study, we evaluated six avian AMPs including 2 truncated cathelicidins, [CATH-1(6–26) and CATH-2(1–15)], and 4 avian β-defensins (ABD1, 2, 6 and 9) for their bactericidal and immunomodulatory activities. Our findings have shown CATH-1(6–26) and ABD1 being the two most potent avian AMPs effective against Gram-positive and Gram-negative bacteria investigated in these studies. Moreover, CATH-1(6–26) inhibited LPS-induced NO production and exhibited dose-dependent cytotoxicity to HD11 cells. While, ABD1 blocked LPS-induced IL-1β gene induction and was non-toxic to HD11 cells. Importantly, in ovo administration of these AMPs demonstrated that ABD1 can offer significant protection from early chick mortality (44% less mortality in ABD1 treated group versus the control group) due to the experimental yolk sac infection caused by avian pathogenic Escherichia coli. Our data suggest that in ovo administration of ABD1 has immunomodulatory and anti-infection activity comparable with CpG ODN. Thus, ABD1 can be a significant addition to potential alternatives to antibiotics for the control of bacterial infections in young chicks.
format article
author Thuy Thi Thu Nguyen
Brenda Allan
Colette Wheler
Wolfgang Köster
Volker Gerdts
Arshud Dar
author_facet Thuy Thi Thu Nguyen
Brenda Allan
Colette Wheler
Wolfgang Köster
Volker Gerdts
Arshud Dar
author_sort Thuy Thi Thu Nguyen
title Avian antimicrobial peptides: in vitro and in ovo characterization and protection from early chick mortality caused by yolk sac infection
title_short Avian antimicrobial peptides: in vitro and in ovo characterization and protection from early chick mortality caused by yolk sac infection
title_full Avian antimicrobial peptides: in vitro and in ovo characterization and protection from early chick mortality caused by yolk sac infection
title_fullStr Avian antimicrobial peptides: in vitro and in ovo characterization and protection from early chick mortality caused by yolk sac infection
title_full_unstemmed Avian antimicrobial peptides: in vitro and in ovo characterization and protection from early chick mortality caused by yolk sac infection
title_sort avian antimicrobial peptides: in vitro and in ovo characterization and protection from early chick mortality caused by yolk sac infection
publisher Nature Portfolio
publishDate 2021
url https://doaj.org/article/9fb659bc8a2141f095f103ae0b6508dc
work_keys_str_mv AT thuythithunguyen avianantimicrobialpeptidesinvitroandinovocharacterizationandprotectionfromearlychickmortalitycausedbyyolksacinfection
AT brendaallan avianantimicrobialpeptidesinvitroandinovocharacterizationandprotectionfromearlychickmortalitycausedbyyolksacinfection
AT colettewheler avianantimicrobialpeptidesinvitroandinovocharacterizationandprotectionfromearlychickmortalitycausedbyyolksacinfection
AT wolfgangkoster avianantimicrobialpeptidesinvitroandinovocharacterizationandprotectionfromearlychickmortalitycausedbyyolksacinfection
AT volkergerdts avianantimicrobialpeptidesinvitroandinovocharacterizationandprotectionfromearlychickmortalitycausedbyyolksacinfection
AT arshuddar avianantimicrobialpeptidesinvitroandinovocharacterizationandprotectionfromearlychickmortalitycausedbyyolksacinfection
_version_ 1718387280999088128